A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome

Inclusion criteria

• ✓. A positive two-test methodology using a sensitive enzyme immunoassay (EIA) or immunofluorescence assay as a first test, followed by a western immunoblot assay for specimens yielding positive or equivocal results for Lyme Disease that has been treated with antibiotics but the symptoms persist post treatment.
• ✓. Must be able to swallow a mixed powder drink.